BioSig new PURE EP subscription model adopted by Mayo Clinic-Phoenix

BioSig Technologies announced that Mayo Clinic-Phoenix-an existing user of the PURE EP Platform-has upgraded to the Platform’s subscription model to gain immediate access to the Company’s latest technological advancements in cardiac arrhythmia identification. Harnessing the power of automation, PURE EP’s latest software features debut unique algorithms that unlock signal data for electrophysiologists conducting even the most challenging ablation procedures. “We are thrilled to roll out our newest, most innovative software to one of our company’s longest standing partners. As we continue building out PURE EP’s software suite, customers will have the flexibility to purchase and add enhancements that meet their needs,” commented Gray Fleming, Chief Commercial Officer of BioSig. “By removing the burden of ownership and maintenance, we’re putting the latest PURE EP developments in physician’s hands as they unfold-unlocking the full potential of the electrophysiology lab.”